Results 271 to 280 of about 98,417 (285)

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Lancet, The, 2008
Jean-Philippe Spanò, Richard Letourneau, Emilio Bajetta   +2 more
exaly  

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

Annals of Oncology, 2015
Armando Santoro, Nicola Personeni, P Foa   +2 more
exaly  

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology, 2019
Chigusa Morizane, J Mizusawa, N Okano
exaly  

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Annals of Oncology, 2012
M Gilabert, E François, L Dahan
exaly  

Gemcitabine

Reactions Weekly, 2013
openaire   +2 more sources

Pancreatic Cancer Chemoresistance to Gemcitabine

Cancers, 2017
Manoj Amrutkar, Gladhaug Ivar P
exaly  

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network

Annals of Oncology, 2012
Silvia Stacchiotti, Elena Palassini, Roberta Sanfilippo   +2 more
exaly  

Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade

Cancer Letters, 2016
Zhengle Zhang, Hengqiang Zhao, Heshui Wu   +2 more
exaly  

Gemcitabine

Reactions Weekly, 2004
  +4 more sources

Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study

Annals of Oncology, 2007
Roberto Labianca, A Hinke, C Louvet
exaly